Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

14/08/2023 07:40

Aug 14 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Jun 30, 2023        Jun 30, 2022       Sep 30, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            51 mln              112 mln            68 mln     
                 (-54.0 pct)         (-4.9 pct)        (-82.4 pct)   
  Operating     loss 620 mln        loss 383 mln       loss 993 mln  
  Recurring     loss 577 mln        loss 305 mln       loss 953 mln  
  Net           loss 578 mln        loss 306 mln       loss 955 mln  
  EPS          loss 107.45 yen     loss 65.02 yen    loss 177.35 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T